Eunyoung Choi Archive — Page 1 of 2
-
January 31, 2024
Fatty acids rewire energy supply chain in stomach cancer development
A study by Vanderbilt researchers has revealed how metabolic changes spurred by fatty acids contribute to the transformation of cells into abnormal versions of themselves that are the precursors to stomach cancer. -
October 5, 2023
Study validates pyrvinium as treatment to prevent stomach cancer
A Vanderbilt study found that a drug that has been used for decades for intestinal pinworms, can be repurposed as a preventative treatment for stomach cancer. -
November 10, 2022
Gastric Cancer Foundation funds Eunyoung Choi research
The Gastric Cancer Foundation has awarded a one-year $100,000 research grant to Eunyoung Choi, PhD, to support her efforts to find a way to disrupt the transformation of dysplastic stem cells into stomach cancer. -
September 1, 2022
Grant supports research to study gastric cancer origins
Vanderbilt researchers have received $5 million in funding from a new initiative by the National Cancer Institute that aims to define how gastric and gastroesophageal junction adenocarcinomas form and evolve at the cellular level. -
June 23, 2022
Study reveals how gastric cancer forms, suggests preventive treatment
Eunyoung Choi, PhD, assistant professor of Surgery, and colleagues identified for the first time that Trop2+/CD133+/CD166+ dysplastic stem cells are a key source of clonal evolution of dysplasia to multiple types of gastric cancer. -
June 2, 2022
Choi, Short receive AGA Research Foundation Awards
Two Vanderbilt researchers have received awards from the AGA Foundation, the charitable arm of the American Gastroenterological Association. -
May 19, 2022
Molecular ‘switch’ may illuminate stomach disorders
An international team that included researchers from Vanderbilt University Medical Center has discovered a molecular switch that induces rapid proliferation of zymogen granule-secreting chief cells in the stomach to regenerate damaged tissue.